Dr Lucas Przymusinski > DLA Piper LLP (US) > New York, United States > Lawyer Profile
DLA Piper LLP (US) Offices
1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States
- Firm Profile
- Go to...
Dr Lucas Przymusinski
Work Department
Litigation, Arbitration and Investigations; Life Sciences
Position
Partner
Career
Dr. Lucas Przymusinski is an internal medicine physician and partner in DLA Piper’s Product Liability, Mass Tort and Product Stewardship group. He focuses his practice on drug and device litigation, mass torts, product liability, and regulatory issues.
Dr. Przymusinski has led the scientific and legal defense of numerous mass tort litigations, representing some of the largest pharmaceutical and medical device manufacturers. He has been involved in every stage of litigation, including strategic assessment and planning, motion practice, expert development, trial and appellate practice.
Dr. Przymusinski also regularly counsels life sciences clients on litigation, regulatory, risk management and mitigation, corporate governance and other product-related issues. He also helps guide clients through the FDA Advisory Committee process and assists in developing strategic responses to product safety-issues, recalls and related FDA enforcement actions.
Languages
English, Polish
Education
J.D., Duke University School of Law; M.D., Albany Medical College; B.S., Duke University
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Industry focus > Cannabis
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Intellectual property > Copyright
- Environment > Environment: regulatory
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Dispute resolution > Corporate investigations and white-collar criminal defense